Effect of Cerebral and Cerebellar rTMS in Stroke Patient
Stroke, Repetitive Transcranial Magnetic Stimulation, rTMS
About this trial
This is an interventional treatment trial for Stroke
Eligibility Criteria
Inclusion Criteria:
- Hemiplegic stroke patients within 1 month after onset
- Moderate to severe motor impairment (Fugl-Meyer assessment <85)
- Cognitive and language functions to perform more than one step of command
- More than 19 years old
Exclusion Criteria:
- Contraindicated to rTMS
- Progressive or unstable stroke
- Pre-existing and active major neurological disease or major psychiatric disease
- A history of advanced liver, kidney, cardiac or pulmonary disease, a terminal medical diagnosis consistent with survival <1 year
Sites / Locations
- Samsung Medical CenterRecruiting
- Samsung Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
Facilitatory cerebral and cerebellar rTMS group
Facilitatory cerebral rTMS group
Inhibitory cerebral and cerebellar rTMS group
Inhibitory cerebral rTMS group
Patients underwent 10 consecutive daily sessions of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the affected primary motor cortex of the hand and high-frequency rTMS over the ipsilateral cerebellar hemisphere.
Patients underwent 10 consecutive daily sessions of high-frequency repetitive transcranial magnetic stimulation (rTMS) over the affected primary motor cortex of the hand and sham high-frequency rTMS over the ipsilateral cerebellar hemisphere.
Patients underwent 10 consecutive daily sessions of continous theta bust stimulation (cTBS) over the unaffected primary motor cortex of the hand and high-frequency rTMS over the ipsilateral cerebellar hemisphere.
Patients underwent 10 consecutive daily sessions of continous theta bust stimulation (cTBS) over the unaffected primary motor cortex of the hand and sham rTMS over the ipsilateral cerebellar hemisphere.